Startup Journal

SAO PAULO, Aug. 11, 2011 /PRNewswire/ -- Companhia de Bebidas das Americas - Ambev [BOVESPA: AMBV4, AMBV3; and NYSE: ABV, ABVc] announces today its results for the 2011 second quarter (Q2 2011). The following financial and operating information, unless otherwise indicated, is presented in nominal Reais and prepared in accordance with International Financial and Reporting Standards (IFRS), and should be read in conjunction with our quarterly financial information for the three and six months period ended June 30, 2011 filed with the CVM and submitted to the SEC.

This press release segregates the impact of organic changes from those arising from changes in scope or currency translation.

Scope changes represent the impact of acquisitions and divestitures other than those eliminated from the base, the start up or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. Unless stated, percentage changes in this press release are both organic and normalized in nature. Whenever used in this document, the term "normalized" refers to performance measures (EBITDA, EBIT, Profit, EPS) before special items. Special items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as indicators of the Company's performance. Comparisons, unless otherwise stated, refer to the second quarter of 2010 (Q2 2010). Values in this release may not add up due to rounding.

OPERATING AND FINANCIAL HIGHLIGHTS

Top line performance: Net sales grew 6.2% driven mainly by price increases across our regions, with Net Revenue/hl growing 7.1% in the period. Organic volume decrease of 0.9% across the regions except for HILA-ex.

Cost of Goods Sold (COGS) and Selling, General & Administrative (SG&A) expenses: COGS/hl increased by 9.3% mainly due to raw materials and packaging costs as well as lower fixed cost dilution, which were partly offset in the quarter by gains in currency hedges. SG&A (excl. depreciation & amortization) increased by 1.6% mainly as a result of general inflation and higher logistic costs partially offset by lower provision for variable compensation and cost savings initiatives.

EBITDA, Operating Cash generation and Profit: Our Normalized EBITDA reached R$ 2,583.6 million in Q2 2011, an organic growth of 9.0%, while margin continued to further expand (+110bps) reaching 44.5% in the period. Cash generated from operations in Q2 was R$ 2,589.3 million, a 1.4% increase as compared to same 2010 period. Our Normalized Profit was R$ 1,837.3 million (+20.4%), while our Normalized Earnings per share (EPS) grew 20.1%.

Payout and Financial discipline: We announced in the quarter a R$ 1.26 billion payment in dividends and interest on own capital (IOC), paid on Aug 5th, totaling R$ 3.06 billion payout year to date.

    Financial highlights - Ambev
     consolidated                                       % As       %
    ----------------------------                        ----      ---
    R$ million                      2Q10      2Q11    Reported  Organic
    Total volumes                 36,896.0  36,181.7      -1.9%    -0.9%
    Beer                          26,783.1  26,093.1      -2.6%    -1.2%
    CSD and NANC                  10,112.9  10,088.6      -0.2%     0.1%

    Net sales                      5,678.4   5,811.6       2.3%     6.2%
    Gross profit                   3,739.4   3,793.0       1.4%     5.2%
    Gross margin                      65.9%     65.3%  -60 bps  -70 bps
    EBITDA                         2,408.4   2,578.9       7.1%     9.4%
    EBITDA margin                     42.4%     44.4%  200 bps  130 bps
    Normalized EBITDA              2,422.9   2,583.6       6.6%     9.0%
    Normalized EBITDA margin          42.7%     44.5%  180 bps  110 bps
    Profit - Ambev holders         1,510.2   1,832.6      21.3%
    Normalized Profit -Ambev
     holders                       1,525.5   1,837.3      20.4%
    No. of share outstanding
     (millions)                    3,095.5   3,104.2
    EPS (R$/shares)                   0.49      0.59      21.0%
    Normalized EPS                    0.49      0.59      20.1%
    --------------                    ----      ----      ----

    Financial highlights - Ambev
     consolidated                                       % As        %
    ----------------------------                        ----       ---
    R$ million                    YTD 10    YTD 11    Reported   Organic
    Total volumes                 77,822.6  76,978.3      -1.1%     -0.3%
    Beer                          56,182.4  55,569.1      -1.1%     -0.2%
    CSD and NANC                  21,640.2  21,409.2      -1.1%     -0.8%

    Net sales                     11,799.8  12,373.7       4.9%      8.5%
    Gross profit                   7,861.8   8,248.1       4.9%      8.4%
                                                                     -10
    Gross margin                      66.6%     66.7%   10 bps       bps
    EBITDA                         5,182.3   5,676.8       9.5%     11.7%
                                                                     130
    EBITDA margin                     43.9%     45.9%  200 bps       bps
    Normalized EBITDA              5,229.4   5,682.1       8.7%     10.9%
                                                                     100
    Normalized EBITDA margin          44.3%     45.9%  160 bps       bps
    Profit - Ambev holders         3,160.4   3,921.2      24.1%
    Normalized Profit -Ambev
     holders                       3,242.1   3,926.5      21.1%
    No. of share outstanding
     (millions)                    3,095.5   3,104.2
    EPS (R$/shares)                   1.02      1.26      23.7%
    Normalized EPS                    1.05      1.26      20.8%
    --------------                    ----      ----      ----

    Note: Earnings per share calculation is based on outstanding shares
    (total existing shares excluding shares held in treasury).

CONTACT: Tatiana S F Rodrigues, Ambev Investor Relations, + 55 (11) 2122-1414, ir@ambev.com.br

SOURCE Companhia de Bebidas das Americas - Ambev